Building health equity: How can we mitigate barriers to diverse clinical trial participation?
As the medical industry strives to promote health equity, addressing the lack of diversity in clinical trials has become a key priority. Despite progress, many groups remain underrepresented. This underrepresentation affects the efficacy and safety of treatments for these patients.